Needham & Company LLC Reiterates "Hold" Rating for Cooper Companies (NASDAQ:COO)

Needham & Company LLC reiterated their hold rating on shares of Cooper Companies (NASDAQ:COO - Free Report) in a research note issued to investors on Thursday morning,Benzinga reports.

A number of other analysts have also recently commented on COO. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Robert W. Baird lowered their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. JPMorgan Chase & Co. lowered their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, Piper Sandler reiterated an "overweight" rating and set a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, Cooper Companies presently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Trading Down 0.6%

Shares of COO traded down $0.47 during trading hours on Thursday, reaching $78.83. The stock had a trading volume of 1,548,951 shares, compared to its average volume of 1,493,548. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. Cooper Companies has a 52 week low of $69.81 and a 52 week high of $112.38. The firm has a 50-day moving average of $80.25 and a 200 day moving average of $89.24. The company has a market cap of $15.76 billion, a P/E ratio of 40.43, a P/E/G ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. On average, sell-side analysts expect that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cooper Companies

Several hedge funds have recently modified their holdings of the stock. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in shares of Cooper Companies by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company's stock valued at $178,977,000 after acquiring an additional 284,943 shares in the last quarter. Woodline Partners LP grew its holdings in shares of Cooper Companies by 0.9% in the 1st quarter. Woodline Partners LP now owns 567,402 shares of the medical device company's stock valued at $47,860,000 after acquiring an additional 4,902 shares in the last quarter. MBB Public Markets I LLC bought a new position in shares of Cooper Companies in the 1st quarter valued at about $331,000. United Services Automobile Association bought a new position in shares of Cooper Companies in the 1st quarter valued at about $414,000. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock valued at $399,340,000 after acquiring an additional 686,751 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.